169 related articles for article (PubMed ID: 18301890)
1. Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells.
Grünebach F; Erndt S; Häntschel M; Heine A; Brossart P
Cancer Immunol Immunother; 2008 Oct; 57(10):1483-91. PubMed ID: 18301890
[TBL] [Abstract][Full Text] [Related]
2. Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.
Schmidt SM; Schag K; Müller MR; Weck MM; Appel S; Kanz L; Grünebach F; Brossart P
Blood; 2003 Jul; 102(2):571-6. PubMed ID: 12576330
[TBL] [Abstract][Full Text] [Related]
3. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors.
Heiser A; Maurice MA; Yancey DR; Coleman DM; Dahm P; Vieweg J
Cancer Res; 2001 Apr; 61(8):3388-93. PubMed ID: 11309297
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen.
Boss CN; Grünebach F; Brauer K; Häntschel M; Mirakaj V; Weinschenk T; Stevanovic S; Rammensee HG; Brossart P
Clin Cancer Res; 2007 Jun; 13(11):3347-55. PubMed ID: 17545542
[TBL] [Abstract][Full Text] [Related]
5. Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.
Yokoyama Y; Grünebach F; Schmidt SM; Heine A; Häntschel M; Stevanovic S; Rammensee HG; Brossart P
Clin Cancer Res; 2008 Sep; 14(17):5503-11. PubMed ID: 18765542
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of RNA pool complexity on stimulatory capacity of RNA-pulsed dendritic cells.
Javorovic M; Wilde S; Zobywalski A; Noessner E; Lennerz V; Wölfel T; Schendel DJ
J Immunother; 2008 Jan; 31(1):52-62. PubMed ID: 18157012
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
[TBL] [Abstract][Full Text] [Related]
8. Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes.
Schag K; Schmidt SM; Müller MR; Weinschenk T; Appel S; Weck MM; Grünebach F; Stevanovic S; Rammensee HG; Brossart P
Clin Cancer Res; 2004 Jun; 10(11):3658-66. PubMed ID: 15173072
[TBL] [Abstract][Full Text] [Related]
9. Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.
Akiyama Y; Maruyama K; Tai S; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
Int J Oncol; 2008 Sep; 33(3):433-41. PubMed ID: 18695871
[TBL] [Abstract][Full Text] [Related]
10. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
[TBL] [Abstract][Full Text] [Related]
11. Generation of populations of antigen-specific cytotoxic T cells using DCs transfected with DNA construct encoding HER2/neu tumor antigen epitopes.
Kuznetsova M; Lopatnikova J; Khantakova J; Maksyutov R; Maksyutov A; Sennikov S
BMC Immunol; 2017 Jun; 18(1):31. PubMed ID: 28633645
[TBL] [Abstract][Full Text] [Related]
12. Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.
Schmidt SM; Schag K; Müller MR; Weinschenk T; Appel S; Schoor O; Weck MM; Grünebach F; Kanz L; Stevanovic S; Rammensee HG; Brossart P
Cancer Res; 2004 Feb; 64(3):1164-70. PubMed ID: 14871853
[TBL] [Abstract][Full Text] [Related]
13. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y
Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell vaccine with mRNA targeted to the proteasome by polyubiquitination.
Hosoi A; Takeda Y; Sakuta K; Ueha S; Kurachi M; Kimura K; Maekawa R; Kakimi K
Biochem Biophys Res Commun; 2008 Jun; 371(2):242-6. PubMed ID: 18423376
[TBL] [Abstract][Full Text] [Related]
15. Induction of antigen-specific cytotoxic T lymphocytes by using monocyte-derived DCs transfected with in vitro-transcribed WT1 or SART1 mRNA.
Narita M; Tochiki N; Saitoh A; Watanabe N; Kaji M; Satoh N; Yamahira A; Nakamura T; Masuko M; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
Med Oncol; 2009 Dec; 26(4):429-36. PubMed ID: 19058036
[TBL] [Abstract][Full Text] [Related]
16. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK
Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946
[TBL] [Abstract][Full Text] [Related]
17. Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.
Siegel S; Wagner A; Kabelitz D; Marget M; Coggin J; Barsoum A; Rohrer J; Schmitz N; Zeis M
Blood; 2003 Dec; 102(13):4416-23. PubMed ID: 12869512
[TBL] [Abstract][Full Text] [Related]
18. Characterization of BAX inhibitor-1 as a novel leukemia-associated antigen.
Schmidt SM; König T; Bringmann A; Held S; von Schwarzenberg K; Heine A; Holderried TA; Stevanovic S; Grünebach F; Brossart P
Leukemia; 2009 Oct; 23(10):1818-24. PubMed ID: 19609282
[TBL] [Abstract][Full Text] [Related]
19. A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemia.
Kronenberger K; Nössner E; Frankenberger B; Wahl U; Dreyling M; Hallek M; Mocikat R
J Immunother; 2008 Oct; 31(8):723-30. PubMed ID: 18779747
[TBL] [Abstract][Full Text] [Related]
20. Dendritic Cells Transfected with a DNA Construct Encoding Tumour-associated Antigen Epitopes Induce a Cytotoxic Immune Response Against Autologous Tumour Cells in a Culture of Mononuclear Cells from Colorectal Cancer Patients.
Kulikova EV; Kurilin VV; Shevchenko JA; Obleukhova IA; Khrapov EA; Boyarskikh UA; Filipenko ML; Shorokhov RV; Yakushenko VK; Sokolov AV; Sennikov SV
Scand J Immunol; 2015 Aug; 82(2):110-7. PubMed ID: 25966778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
